Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease

被引：26
|
作者：
Caraci, Filippo [1 ,2 ]
Nicoletti, Ferdinando [3 ,4 ]
Copani, Agata [1 ,5 ]
机构：
[1] Univ Catania, Dept Drug Sci, Catania, Italy
[2] Oasi Inst Res Mental Retardat & Brain Aging IRCCS, Troina, Italy
[3] Univ Rome Sapienza, Dept Physiol & Pharmacol, Rome, Italy
[4] Neuromed IRCCS, Pozzilli, Italy
[5] CNR, Inst Biostruct & Bioimaging, Catania, Italy
来源：
CURRENT OPINION IN PHARMACOLOGY | 2018年 / 38卷
关键词：
CELLULAR PRION PROTEIN; CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA OLIGOMERS; LONG-TERM DEPRESSION; A-BETA; MOUSE MODEL; ALLOSTERIC MODULATION; COGNITIVE IMPAIRMENT; RAT HIPPOCAMPUS; CEREBRAL-CORTEX;
D O I：
10.1016/j.coph.2017.12.001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
A dysfunction of glutamate signaling is implicated at several levels in the pathogenesis of Alzheimer's disease. Currently, metabotropic glutamate receptors, which have a wide distribution in the central nervous system and activate a multitude of cell signaling pathways, are pursued as targets for therapeutic intervention in Alzheimer's disease. Research is still limited, but results underscore the relevance of ongoing studies. Here we discuss the latest updates regarding metabotropic glutamate receptors and their role in Alzheimer's disease, as well as promising metabotropic glutamate receptor ligands that have been investigated in preclinical models of Alzheimer's disease.
引用
收藏
页码：1 / 7
页数：7
相关论文
共 50 条
  • [41] The role of striatal metabotropic glutamate receptors in Parkinson's disease
    K. Ossowska
    J. Konieczny
    J. Wardas
    K. Gołembiowska
    S. Wolfarth
    A. Pilc
    [J]. Amino Acids, 2002, 23 : 193 - 198
  • [42] Huntington’s Disease and Group I Metabotropic Glutamate Receptors
    Fabiola M. Ribeiro
    Rita G. W. Pires
    Stephen S. G. Ferguson
    [J]. Molecular Neurobiology, 2011, 43 : 1 - 11
  • [43] Huntington's Disease and Group I Metabotropic Glutamate Receptors
    Ribeiro, Fabiola M.
    Pires, Rita G. W.
    Ferguson, Stephen S. G.
    [J]. MOLECULAR NEUROBIOLOGY, 2011, 43 (01) : 1 - 11
  • [44] The role of striatal metabotropic glutamate receptors in Parkinson's disease
    Ossowska, K
    Konieczny, J
    Wardas, J
    Golembiowska, K
    Wolfarth, S
    Pilc, A
    [J]. AMINO ACIDS, 2002, 23 (1-3) : 193 - 198
  • [45] Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease
    Amalric, Marianne
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2015, 20 : 29 - 34
  • [46] Targeting Metabotropic Glutamate Receptors (mGluRs) in Parkinson's Disease
    Amalric, M.
    [J]. CURRENT NEUROPHARMACOLOGY, 2014, 12 : 2 - 2
  • [47] Metabotropic glutamate receptors: Potential drug targets
    Knopfel, T
    Gasparini, F
    [J]. DRUG DISCOVERY TODAY, 1996, 1 (03) : 103 - 108
  • [48] Therapeutic Potential of Metabotropic Glutamate Receptor Modulators
    Hovelso, N.
    Sotty, F.
    Montezinho, L. P.
    Pinheiro, P. S.
    Herrik, K. F.
    Mork, A.
    [J]. CURRENT NEUROPHARMACOLOGY, 2012, 10 (01) : 12 - 48
  • [49] Metabotropic glutamate receptors and opiate analgesia - Therapeutic implications
    Blackburn-Munro, G
    [J]. PAIN FORUM, 1999, 8 (01): : 19 - 21
  • [50] Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease
    Abd-Elrahman, Khaled S.
    Ferguson, Stephen S. G.
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2022, 62 : 235 - 254
12345